Forte Biosciences, Inc. (FBRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-113.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $36.0K | $18.04M | $41.0K | $49.0K |
| Operating Income | -$70.66M | -$36.60M | -$32.49M | -$13.90M | -$21.49M | -$46.28M | -$4.06M | -$45.85M | -$37.63M | -$31.69M |
| Net Income | -$69.38M | -$35.48M | -$31.48M | -$13.88M | -$21.71M | -$46.49M | -$4.07M | -$48.95M | -$38.93M | -$33.48M |
| EPS (Diluted) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | — | — | — | — | — |
| Total Assets | $82.78M | $61.56M | $38.98M | $42.00M | $43.31M | $61.24M | $7.66M | $103.08M | $92.07M | $35.35M |
| Total Liabilities | $21.79M | $9.08M | — | — | — | — | $17.31M | $44.94M | $20.99M | $28.36M |
| Shareholders' Equity | $60.99M | $52.48M | $35.31M | $38.82M | $41.55M | $58.98M | -$4.77M | -$736.0K | $71.08M | -$124.42M |
| Cash & Equivalents | $76.96M | $22.24M | $37.12M | $41.10M | $42.04M | $58.77M | $6.94M | $40.81M | $35.93M | $5.51M |
| Operating Cash Flow | -$50.88M | -$30.75M | -$28.71M | -$8.19M | -$16.68M | -$18.42M | -$2.77M | -$34.47M | -$31.13M | -$29.54M |
| Capital Expenditures | $116.0K | $37.0K | $88.0K | — | — | — | $162.0K | $1.97M | $655.0K | $525.0K |
| Shares Outstanding | 12.95M | 6.39M | 1.45M | 21.00M | 14.75M | 12.83M | 2.11M | 23.00M | 19.88M | 2.20M |